3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Ovarian Neoplasms
2
Neoplasm Metastasis
2
Multiple Myeloma
2
Lymphoma
2
Hematologic Neoplasms
2
Fallopian Tube Neoplasms
2
Carcinoma, Renal Cell
2
Uterine Neoplasms
1
Uterine Cervical Neoplasms
1
Urinary Bladder Neoplasms
1
Thyroid Neoplasms
1
Stomach Neoplasms
1
Rectal Neoplasms
1
Prostatic Neoplasms
1
Pancreatic Neoplasms
1
Neoplasms
1
Meningeal Carcinomatosis
1
Melanoma
1
Lung Neoplasms
1
Glioma
1
Esophageal Squamous Cell Carcinoma
1
Esophageal Neoplasms
1
Endometrial Neoplasms
1
Colorectal Neoplasms
1
Colonic Neoplasms
1
Carcinoma, Hepatocellular
1
Carcinoma
1
Brenner Tumor
1
Breast Neoplasms
1
Brain Neoplasms
1
Interventions
Vincristine
8
X-Rays
6
Temozolomide
6
Phantoms, Imaging
6
Magnetic Resonance Spectroscopy
6
Cyclophosphamide
6
Specimen Handling
5
Irinotecan
5
Nuclear Medicine Department, Hospital
4
Biopsy
4
Radiotherapy
3
Radiation
3
Dactinomycin
3
ulixertinib
2
tipifarnib
2
tazemetostat
2
selpercatinib
2
palbociclib
2
larotrectinib
2
ivosidenib
2
fludarabine
2
ensartinib
2
Vinorelbine
2
Proton Therapy
2
LY3023414
2
Ifosfamide
2
Filgrastim
2
Etoposide
2
Doxorubicin
2
Dexrazoxane
2
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Rhabdomyosarcoma
×
adavosertib
×
90 days
×
Clear all
No trials found.